These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38858661)

  • 1. Repositioning of antiarrhythmics for prostate cancer treatment: a novel strategy to reprogram cancer-associated fibroblasts towards a tumor-suppressive phenotype.
    Doldi V; Tortoreto M; Colecchia M; Maffezzini M; Percio S; Giammello F; Brandalise F; Gandellini P; Zaffaroni N
    J Exp Clin Cancer Res; 2024 Jun; 43(1):161. PubMed ID: 38858661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis.
    Zhang Y; Zhao J; Ding M; Su Y; Cui D; Jiang C; Zhao S; Jia G; Wang X; Ruan Y; Jing Y; Xia S; Han B
    J Exp Clin Cancer Res; 2020 Dec; 39(1):282. PubMed ID: 33317606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis.
    Neuwirt H; Bouchal J; Kharaishvili G; Ploner C; Jöhrer K; Pitterl F; Weber A; Klocker H; Eder IE
    Cell Commun Signal; 2020 Jan; 18(1):11. PubMed ID: 31980029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.
    Moatassim-Billah S; Duluc C; Samain R; Jean C; Perraud A; Decaup E; Cassant-Sourdy S; Bakri Y; Selves J; Schmid H; Martineau Y; Mathonnet M; Pyronnet S; Bousquet C
    Oncotarget; 2016 Jul; 7(27):41584-41598. PubMed ID: 27177087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Nox4-dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal-mediated protumorigenic interactions.
    Sampson N; Brunner E; Weber A; Puhr M; Schäfer G; Szyndralewiez C; Klocker H
    Int J Cancer; 2018 Jul; 143(2):383-395. PubMed ID: 29441570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
    Goulet CR; Champagne A; Bernard G; Vandal D; Chabaud S; Pouliot F; Bolduc S
    BMC Cancer; 2019 Feb; 19(1):137. PubMed ID: 30744595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration.
    Cioni B; Nevedomskaya E; Melis MHM; van Burgsteden J; Stelloo S; Hodel E; Spinozzi D; de Jong J; van der Poel H; de Boer JP; Wessels LFA; Zwart W; Bergman AM
    Mol Oncol; 2018 Aug; 12(8):1308-1323. PubMed ID: 29808619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation.
    Coleman DT; Gray AL; Stephens CA; Scott ML; Cardelli JA
    Oncotarget; 2016 May; 7(22):32200-9. PubMed ID: 27058757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF β2.
    Ting HJ; Deep G; Jain AK; Cimic A; Sirintrapun J; Romero LM; Cramer SD; Agarwal C; Agarwal R
    Mol Carcinog; 2015 Sep; 54(9):730-41. PubMed ID: 24615813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression.
    Shen T; Li Y; Zhu S; Yu J; Zhang B; Chen X; Zhang Z; Ma Y; Niu Y; Shang Z
    J Exp Clin Cancer Res; 2020 Feb; 39(1):36. PubMed ID: 32066485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β1-activated cancer-associated fibroblasts promote breast cancer invasion, metastasis and epithelial-mesenchymal transition by autophagy or overexpression of FAP-α.
    Huang M; Fu M; Wang J; Xia C; Zhang H; Xiong Y; He J; Liu J; Liu B; Pan S; Liu F
    Biochem Pharmacol; 2021 Jun; 188():114527. PubMed ID: 33741330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mutated TRPA1 ion channel by resveratrol in human prostate cancer associated fibroblasts (CAF).
    Vancauwenberghe E; Noyer L; Derouiche S; Lemonnier L; Gosset P; Sadofsky LR; Mariot P; Warnier M; Bokhobza A; Slomianny C; Mauroy B; Bonnal JL; Dewailly E; Delcourt P; Allart L; Desruelles E; Prevarskaya N; Roudbaraki M
    Mol Carcinog; 2017 Aug; 56(8):1851-1867. PubMed ID: 28277613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immortalized Cancer-associated Fibroblasts Promote Prostate Cancer Carcinogenesis, Proliferation and Invasion.
    Yu S; Jiang Y; Wan F; Wu J; Gao Z; Liu D
    Anticancer Res; 2017 Aug; 37(8):4311-4318. PubMed ID: 28739723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated fibroblasts stimulate primary tumor growth and metastatic spread in an orthotopic prostate cancer xenograft model.
    Linxweiler J; Hajili T; Körbel C; Berchem C; Zeuschner P; Müller A; Stöckle M; Menger MD; Junker K; Saar M
    Sci Rep; 2020 Jul; 10(1):12575. PubMed ID: 32724081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
    Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
    Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death.
    Cheteh EH; Augsten M; Rundqvist H; Bianchi J; Sarne V; Egevad L; Bykov VJ; Östman A; Wiman KG
    Cell Death Dis; 2017 Jun; 8(6):e2848. PubMed ID: 28569790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated fibroblasts induce an aggressive phenotypic shift in non-malignant breast epithelial cells via interleukin-8 and S100A8.
    Lim H; Koh M; Jin H; Bae M; Lee SY; Kim KM; Jung J; Kim HJ; Park SY; Kim HS; Moon WK; Hwang S; Cho NH; Moon A
    J Cell Physiol; 2021 Oct; 236(10):7014-7032. PubMed ID: 33748944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.
    Ishimoto T; Miyake K; Nandi T; Yashiro M; Onishi N; Huang KK; Lin SJ; Kalpana R; Tay ST; Suzuki Y; Cho BC; Kuroda D; Arima K; Izumi D; Iwatsuki M; Baba Y; Oki E; Watanabe M; Saya H; Hirakawa K; Baba H; Tan P
    Gastroenterology; 2017 Jul; 153(1):191-204.e16. PubMed ID: 28390866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of FGF9 and NOVA1 in cancer-associated fibroblasts promotes cell proliferation, invasion and migration of triple negative breast cancer.
    Zhang B; Liu Y; Yu J; Lin X
    Drug Dev Res; 2024 May; 85(3):e22185. PubMed ID: 38657094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glypican-1 expression induces an activated fibroblast phenotype in a human bone marrow-derived stromal cell-line.
    Kaur SP; Verma A; Lee HK; Barnett LM; Somanath PR; Cummings BS
    Sci Rep; 2021 Apr; 11(1):9262. PubMed ID: 33927256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.